Democratizing SPR: Bringing the gold standard into your everyday lab

Surface plasmon resonance (SPR) is considered a gold standard technique for drug screening but instruments are traditionally only found in large pharmaceutical companies with high-throughput and automation design in mind. As a result, SPR is seen as an inaccessible option, being complex and costly to operate. However, SPR can and should be available for multi-faceted biosensing applications as it is inherently a sensitive, real-time, and label-free technique.

Affinité Instruments has made it its mission to offer portable, affordable and easy-to-use SPR to enable all life science researchers to use it as a tool for quick binding analysis, bioproduction quality control, biomarker identification, assay development, and even in vitro diagnostics.

In this webinar, you will have the opportunity to hear from Prof. Jean-François Masson, from the Université de Montréal, Canada, as he shares his experiences in developing portable SPR instrumentation for clinical and medical applications. Horizon 2020 CorDial-S project leader, Prof. Sabine Szunerits, from the Université de Lille, France, will talk about her latest work using portable SPR to develop saliva-based point of care tests to detect SARS-CoV-2. Plus, hear from an Affinité application scientist, who will explain what it really means to have a portable SPR in your lab and how it can act as a ‘swiss army knife’ in any life science lab to be used anytime, anywhere.

Key Learning Objectives:

• Understand how SPR has evolved from pharma instrumentation into a portable format, and learn its advantages
• Learn about how portable SPR can be used in assay development and in turn used in point of care in vitro diagnostics
• Learn about how portable SPR can be part of everyday workflows to increase R&D efficiency

Who Should Attend:

• Researchers studying biomolecular interactions who need easy access to get binding, affinity, and biokinetics data
• Clinical labs who want to speed up and reduce cost of ELISA-based assays
• Organizations developing lateral flow assays
• R&D labs who want to increase confidence and save cost before high-thoughput SPR runs
• Companies who want to quickly and economically bring multiplex tests onto a sensitive point of care platform